ANRO vs ARE · $60.1M cap vs P/E 100, rev $662.8M
Alto Neuroscience, Inc. (ANRO) versus Alexandria Real Estate Equities Inc (ARE) — a side-by-side from cached financials, not a winner call.
Alto Neuroscience, Inc. (ANRO) is a biotechnology company listed on US.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
ANRO does not have a complete income-statement cache yet.
Latest reported ARE revenue for 2026-06-30 was $662.8M. Net income was -$72.8M. Revenue was down 1.2% from 2026-03-31 to 2026-06-30. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
ANRO currently screens at market cap $60.1M. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
Not investment advice. Open the ANRO and ARE stock pages for the full models.
Not investment advice.